Malignant disease as an incidental finding at 18F-FDG-PET/CT scanning in patients with granulomatous lung disease

Nuclear Medicine Communications

Volumn 36, Issue 5, 2015, Pages 430-437

  Huber, Helmut ^a   Hodolic, Marina ^b   Stelzmüller, Ingrid ^a   Wunn, Rainer ^a   Hatzl, Margit ^a   Fellner, Franz ^a,d   Lamprecht, Bernd ^a   Rubello, Domenico ^e,f   Colletti, Patrick M ^g   Gabriel, Michael ^a,c  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b IASON GmbH   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Department of Imaging ^*  (Italy)

^f PET/CT Centre   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

18F FDG PET CT; Granulomatous disease; Incidentaloma; Lung

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGE DISTRIBUTION; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INCIDENTAL FINDING; INCIDENTALOMA; LUNG GRANULOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-CT SCANNER; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RADIATION DOSE; SARCOIDOSIS; TUBERCULOSIS; AGE; AGED; GRANULOMA; LABORATORY DIAGNOSIS; LUNG NEOPLASMS; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOMA; HUMANS; INCIDENTAL FINDINGS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84927566744     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000274     Document Type: Article

References (41)

1. Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 1999; 40:556-565.
2. Keijsers RGM, van den Heuvel DAF, Grutters JC. Imaging the inflammatory activity of sarcoidosis. Eur Respir J 2013; 41:743-751.
3. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007; 28:36-52.
4. Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001; 42:1551-1555.
5. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Sarcoidosis and tuberculosis: the same disease with different manifestations or similar manifestations of different disorders. Curr Opin Pulm Med 2012; 18:506-516.
6. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-2165.
7. Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin North Am 2005; 89:817-828.
8. Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease. Front Immunol 2013; 4: :98.
9. Soussan M, Brillet PY, Mekinian A, Khafagy A, Nicolas P, Vessieres A, Brauner M. Patterns of pulmonary tuberculosis on FDG-PET/CT. Eur J Radiol 2012; 81:2872-2876.
10. Soussan M, Augier A, Brillet PY, Weinmann P, Valeyre D. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. Clin Nucl Med 2014; 39:e146-e159.
11. Love C, Thomas MB, Palestro CJT. FDG PET of infection and inflammation. Radiographics 2005; 25:1357-1368.
12. Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J 2010; 100:598-601.
13. Ambrosini V, Nicolini S, Caroli P, Nanni C, Massaro A, Marzola MC, et al. PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol 2012; 81:988-1001.
14. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400.
15. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 1993; 186:415-422.
16. Cummings SR, Lillington GA, Richard RJ. Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. Am Rev Respir Dis 1986; 134:449-452.
17. Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med 2013; 43:404-411.
18. Harkirat S, Anana SS, Indrajit LK, Dash AK. Pictorial essay: PET/CT in tuberculosis. Indian J Radiol Imaging 2008; 18:141-147.
19. Mana J, Gamez C. Molecular imaging in sarcoidosis. Curr Opin Pulm Med 2011; 17:325-331.
20. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42:1412-1417.
21. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 2007; 32:607-612.
22. Pavic M, Pasquet F. Granulomatosis and cancer. In: Kalantar Motamedi Mohammad Hosein, editor. Sarcoidosis diagnosis and management. Cleveland: InTech; 2011.
23. Kamboj M, Kent A, Sepkowitz G. The risk of tuberculosis in patients with cancer. Clin Infect Dis 2006; 42:1592-1595.
24. Li W, Holdeman K, Laurini JA, Bierman PJ, Vose JM, Bociek RG, Armitage JO. Sarcoidosis mimicking recurrent lymphoma. Am J Hematol 2012; 87:711-712.
25. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132:1949-1953.
26. 18F-FDG PET/CT. Am J Roentgenol 2011; 197:341-347.
27. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009; 30:240-244.
28. Sim YT, Poon FW. Imaging of solitary pulmonary nodule - a clinical review. Quant Imaging Med Surg 2013; 3:316-326.
29. Opaka L, Kunikowska J, Podgajny Z, Szołkowska M, Błasińska-Przerwa K, Burakowska B, et al. Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions - own experience. Pneumonol Alergol Pol 2014; 82:198-205.
30. Nanni C, Zompatori M, Ambrosini V, Montesi V, Mezzetti S, Ferretti A, et al. The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. Biomed Pharmacother 2013; 67:172-178.
31. Nanni C, Rossetti V, Zompatori M, Ambrosini V, Montesi V, Mascherini D, et al. Performance of FDG PET/ceCT in the evaluation of patients with lung cancer. Biomed Pharmacother 2014; 68:219-223.
32. Grgic A, Yüksel Y, Gröschel A, Schäfers HJ, Sybrecht GW, Kirsch CM, Hellwig D. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging 2010; 37:1087-1094.
33. Sathekge M, Maes A, D'Asseler Y, Vorster M, Van de Wiele C. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals. Nucl Med Commun 2012; 33:581-590.
34. 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis. Acta Radiol 2013; 54:770-777.
35. Demir Y, Polack BP, Karaman C, Ozdoʇan O, Sürücü E, Ayhan S, et al. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules. Nucl Med Commun 2014; 35:260-267.
36. Huang YE, Lu HI, Liu FY, Huang YJ, Lin MC, Chen CF, Wang PW. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease. J Radiat Res 2012; 53:306-312.
37. Maffione AM, Grassetto G, Rampin L, Chondrogiannis S, Marzola MC, Ambrosini V, Rubello D. Molecular imaging of pulmonary nodules. Am J Roentgenol 2014; 202:W217-W223.
38. Houston KA, Henley SJ, Li J,White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009. Lung Cancer 2014; 86:22-28.
39. Oberaigner W, Geiger-Gritsch S. Prediction of cancer incidence in Tyrol/Austria for year of diagnosis 2020. Wien Klin Wochenschr 2014; 126 (19-20):642-649.
40. Leung CC, Hui L, Lee RS, Lam TH, Yew WW, Hui DS, et al. Tuberculosis is associated with increased lung cancer mortality. Int J Tuberc Lung Dis 2013; 17:687-692.
41. Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 2011; 6:32-37.